Your browser doesn't support javascript.
loading
Early-onset autoimmunity associated with SOCS1 haploinsufficiency.
Hadjadj, Jérôme; Castro, Carla Noemi; Tusseau, Maud; Stolzenberg, Marie-Claude; Mazerolles, Fabienne; Aladjidi, Nathalie; Armstrong, Martin; Ashrafian, Houman; Cutcutache, Ioana; Ebetsberger-Dachs, Georg; Elliott, Katherine S; Durieu, Isabelle; Fabien, Nicole; Fusaro, Mathieu; Heeg, Maximilian; Schmitt, Yohan; Bras, Marc; Knight, Julian C; Lega, Jean-Christophe; Lesca, Gaetan; Mathieu, Anne-Laure; Moreews, Marion; Moreira, Baptiste; Nosbaum, Audrey; Page, Matthew; Picard, Cécile; Ronan Leahy, T; Rouvet, Isabelle; Ryan, Ethel; Sanlaville, Damien; Schwarz, Klaus; Skelton, Andrew; Viallard, Jean-Francois; Viel, Sebastien; Villard, Marine; Callebaut, Isabelle; Picard, Capucine; Walzer, Thierry; Ehl, Stephan; Fischer, Alain; Neven, Bénédicte; Belot, Alexandre; Rieux-Laucat, Frédéric.
Afiliación
  • Hadjadj J; Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
  • Castro CN; Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
  • Tusseau M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Stolzenberg MC; Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
  • Mazerolles F; Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
  • Aladjidi N; Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
  • Armstrong M; Université de Paris, Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 24 boulevard du Montparnasse, 75015, Paris, France.
  • Ashrafian H; Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
  • Cutcutache I; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE), CIC 1401, Inserm CICP, Bordeaux, France.
  • Ebetsberger-Dachs G; Pediatric Oncology Hematology Unit, University Hospital, place Amélie Raba Léon, CIC 1401, Inserm, CICP, Bordeaux, France.
  • Elliott KS; Translational Medicine, UCB Pharma, Braine-l'Alleud, Belgium.
  • Durieu I; Experimental Therapeutics, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Fabien N; Translational Medicine, UCB Pharma, Slough, United Kingdom.
  • Fusaro M; Department of Pediatrics, Kepler University Hospital and School of Medicine, Johannes Kepler University, Linz, Austria.
  • Heeg M; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Schmitt Y; Internal Medicine and Vascular Pathology Department, Adult Cystic Fibrosis Center, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Bras M; EA 7425 HESPER. Université de Lyon, Lyon, France.
  • Knight JC; Immunology laboratory; Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Lega JC; Study Center for Primary Immunodeficiencies, AP-HP, Necker Hospital for Sick Children, Paris, France.
  • Lesca G; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Mathieu AL; Genomic Core Facility, INSERM UMR1163, Imagine Institute, Paris, France.
  • Moreews M; Université de Paris, IHU-Imagine, 24 boulevard du Montparnasse, Paris, 75015, France.
  • Moreira B; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Nosbaum A; Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Page M; National Referee Centre for Pediatric-Onset Rheumatism and Autoimmune Diseases (RAISE), Lyon, France.
  • Picard C; UMR 5558, Equipe Evaluation et Modélisation des Effets Thérapeutiques, Laboratoire de Biométrie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, Lyon, France.
  • Ronan Leahy T; Service de Génétique, Hospices Civils de Lyon - GHE, and Institut Neuromyogène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
  • Rouvet I; Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
  • Ryan E; Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
  • Sanlaville D; Immunology Laboratory, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Schwarz K; Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
  • Skelton A; Allergy and Clinical Immunology department, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Viallard JF; Translational Medicine, UCB Pharma, Braine-l'Alleud, Belgium.
  • Viel S; Institut de Pathologie Multisite, Groupement Hospitalier Est, Hospices Civils de Lyon, UCBL Lyon 1 University, Lyon, France.
  • Villard M; Department of Paediatric Immunology and Infectious Diseases, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Callebaut I; Centre de biotechnologie cellulaire et Biothèque, Groupe Hospitalier Est, Hospices Civils de Lyon, 69677, Bron, France.
  • Picard C; Department of Paediatrics, University Hospital Galway, Co, Galway, Ireland.
  • Walzer T; Service de Génétique, Hospices Civils de Lyon - GHE, and Institut Neuromyogène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
  • Ehl S; Institute for Transfusion Medicin, University Ulm and Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, 89081, Ulm, Germany.
  • Fischer A; Translational Medicine, UCB Pharma, Slough, United Kingdom.
  • Neven B; Département de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire Haut Lévêque, Université de Bordeaux, Pessac, France.
  • Belot A; Centre International de Recherche en Infectiologie, CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, University of Lyon, Lyon, France.
  • Rieux-Laucat F; Service d'Immunologie Biologique, Groupement Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
Nat Commun ; 11(1): 5341, 2020 10 21.
Article en En | MEDLINE | ID: mdl-33087723
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Autoinmunidad / Proteína 1 Supresora de la Señalización de Citocinas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Autoinmunidad / Proteína 1 Supresora de la Señalización de Citocinas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Francia